The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neutrophil extracellular traps (NETs) and thrombosis (Thr) in pancreaticobiliary cancer (PBC).
 
Christos Fountzilas
Research Funding - Astellas Pharma (Inst); Corcept Therapeutics (Inst); ERYTECH Pharma (Inst); Incyte (Inst); Ipsen (Inst); Kinex (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Rafael Pharmaceuticals (Inst); Seagen (Inst); Syndax (Inst)
 
Han Yu
No Relationships to Disclose
 
Anm Nazmul Khan
No Relationships to Disclose
 
Thejaswini Giridharan
No Relationships to Disclose
 
Alok A. Khorana
Honoraria - Anthos Therapeutics; Bayer; Halozyme; Janssen; Medscape; Nektar; Pfizer
Consulting or Advisory Role - Anthos Therapeutics; Bayer; Janssen; Pharmacyclics; Pharmacyte Biotech; Seagen
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Leap Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Janssen; Seagen
 
Renuka V. Iyer
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Exelixis; Ipsen; Lexicon; Merck; Novartis; QED therapeutics; Sun pharma
Research Funding - Cleveland BioLabs (Inst); Genentech/Roche (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Brahm H. Segal
Consulting or Advisory Role - Merck